ADC Therapeutics
ADCT
ADCT
59 hedge funds and large institutions have $801M invested in ADC Therapeutics in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.6% more ownership
Funds ownership: 41.19% → 42.79% (+1.6%)
21% less capital invested
Capital invested by funds: $1.01B → $801M (-$210M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
59
Holding in Top 10
3
Calls
$8.9M
Puts
$2.38M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$19M | |
| 3 | +$13.4M | |
| 4 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$8.99M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.79M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$7.85M | |
| 3 | -$5.3M | |
| 4 |
BlackRock
New York
|
-$5.28M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$4.26M |